Yu Sheng-Qiang, Lai Kuo-Pao, Xia Shu-Jie, Chang Hong-Chiang, Chang Chawnshang, Yeh Shuyuan
Department of Urology, The First People's Hospital of Shanghai Jiao Tong University, Shanghai, China.
Asian J Androl. 2009 Jan;11(1):39-48. doi: 10.1038/aja.2008.44. Epub 2008 Dec 22.
The androgen receptor (AR) plays an important role in the development and progression of prostate cancer (PCa). Androgen deprivation therapy is initially effective in blocking tumor growth, but it eventually leads to the hormone-refractory state. The detailed mechanisms of the conversion from androgen dependence to androgen independence remain unclear. Several PCa cell lines were established to study the role of AR in PCa, but the results were often inconsistent or contrasting in different cell lines, or in the same cell line grown under different conditions. The cellular and molecular alteration of epithelial cells and their microenvironments are complicated, and it is difficult to use a single cell line to address this important issue and also to study the pathophysiological effects of AR. In this paper, we summarize the different effects of AR on multiple cell lines and show the disadvantages of using a single human PCa cell line to study AR effects on PCa. We also discuss the advantages of widely used epithelium-stroma co-culture systems, xenograft mouse models, and genetically engineered PCa mouse models. The combination of in vitro cell line studies and in vivo mouse models might lead to more credible results and better strategies for the study of AR roles in PCa.
雄激素受体(AR)在前列腺癌(PCa)的发生和发展中起着重要作用。雄激素剥夺疗法最初在阻断肿瘤生长方面有效,但最终会导致激素抵抗状态。从雄激素依赖转变为雄激素非依赖的详细机制仍不清楚。已建立了几种前列腺癌细胞系来研究AR在PCa中的作用,但在不同细胞系中,或在不同条件下培养的同一细胞系中,结果往往不一致或相互矛盾。上皮细胞及其微环境的细胞和分子改变很复杂,很难用单一细胞系来解决这一重要问题,也难以研究AR的病理生理效应。在本文中,我们总结了AR对多种细胞系的不同影响,并展示了使用单一人类前列腺癌细胞系研究AR对PCa影响的缺点。我们还讨论了广泛使用的上皮-基质共培养系统、异种移植小鼠模型和基因工程前列腺癌小鼠模型的优点。体外细胞系研究和体内小鼠模型的结合可能会产生更可靠的结果,并为研究AR在PCa中的作用提供更好的策略。